Yselty Receives Additional Indication for Endometriosis in Taiwan
Filed with TSE · · 2 pages · English
Kissei Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Kissei Pharmaceutical
- Financial Briefing for the Second Quarter (Interim) of the Fiscal Year Ended March 31, 2027 (Fiscal 2026)
- Notice Concerning the Results of the Acquisition of Treasury Shares through ToSTNeT-3
- Supplementary Explanatory Materials on Financial Results for the Six Months Ended September 30, 2026
- Notice Concerning the Purchase of Treasury Shares through ToSTNeT-3
- Notice Concerning Status of Acquisition of Treasury Shares
Follow Kissei Pharmaceutical into a list and get an email when it puts out news.
Follow Kissei Pharmaceutical